I.C.O. Paul Papin
I.C.O. Paul Papin
Angers, France1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers | human papillomavirus-related penile squamous cell carcinoma, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-05 | NCT03260023 |